The ADAPTABLE trial and aspirin dosing in secondary prevention for patients with coronary artery disease
A Johnston, WS Jones, AF Hernandez - Current cardiology reports, 2016 - Springer
… with either high or low-dose aspirin plus clopidogrel for … increased risk of bleeding with
aspirin treatment is widely recognized but the dose-risk relationship, especially in doses between …
aspirin treatment is widely recognized but the dose-risk relationship, especially in doses between …
Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous …
… increased risk of recurrent ischemia or death. Completed trials make a compelling case for
double therapy with clopidogrel, not aspirin… greater risk of bleeding compared with clopidogrel …
double therapy with clopidogrel, not aspirin… greater risk of bleeding compared with clopidogrel …
The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders
AT Cohen, S Imfeld, J Markham, S Granziera - Thrombosis research, 2015 - Elsevier
… medical patients at increased risk of thrombosis who are not currently experiencing bleeding
and are not at high risk of … Antiplatelet therapy with aspirin plus clopidogrel or aspirin alone (…
and are not at high risk of … Antiplatelet therapy with aspirin plus clopidogrel or aspirin alone (…
Clopidogrel non-responsiveness and risk of cardiovascular morbidity
… outcomes in patients with coronary artery disease (CAD) … date, the dual therapy with aspirin
and clopidogrel, that has been … with an increased risk of adverse clinical cardiac events (OR …
and clopidogrel, that has been … with an increased risk of adverse clinical cardiac events (OR …
Aspirin for the primary prevention of cardiovascular events: recommendation and rationale
US Preventive Services Task Force* - Annals of Internal Medicine, 2002 - acpjournals.org
… evidence that aspirin decreases the incidence of coronary heart disease in adults who
are at increased risk for heart disease. It also found good evidence that aspirin increases the …
are at increased risk for heart disease. It also found good evidence that aspirin increases the …
Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from …
… (DAPT) consisting of aspirin (ASA) and clopidogrel is a cornerstone in … to prevent early and
late in-stent thromboses [5, 6]. … between PPI and clopidogrel to patients who are at high risk of …
late in-stent thromboses [5, 6]. … between PPI and clopidogrel to patients who are at high risk of …
[HTML][HTML] Pros and cons of aspirin for the primary prevention of cardiovascular events: a secondary study of trial sequential analysis
B Zhao, Q Wu, L Wang, C Liao, Y Dong, J Xu… - Frontiers in …, 2021 - frontiersin.org
… Currently, many patients are at high risk because their health is influenced by occlusive …
In this study, CV event risk was reduced by 11% in the low 10-y MACE% risk group. …
In this study, CV event risk was reduced by 11% in the low 10-y MACE% risk group. …
Aspirin and clopidogrel: a sweeping combination in cardiology
AS Manolis, S Tzeis, G Andrikopoulos… - … -Cardiovascular & …, 2005 - ingentaconnect.com
… for the treatment of symptomatic coronary artery disease. … of aspirin to prevent the recurrence
of a vascular event in 10-20… of increased risk of recurrent cardiovascular events during a 6-…
of a vascular event in 10-20… of increased risk of recurrent cardiovascular events during a 6-…
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
S Matetzky, B Shenkman, V Guetta, M Shechter… - Circulation, 2004 - Am Heart Assoc
… PCI who were already receiving aspirin was followed by a … patients with STEMI were resistant
to clopidogrel and subsequently were at increased risk of recurrent cardiovascular events …
to clopidogrel and subsequently were at increased risk of recurrent cardiovascular events …
[HTML][HTML] Clinical importance of aspirin and clopidogrel resistance
G Feher, A Feher, G Pusch, K Koltai… - … journal of cardiology, 2010 - ncbi.nlm.nih.gov
… to aspirin because they exhibited significantly higher risks of … in preventing vascular events
as higher aspirin doses (500 to … of adverse cardiovascular events among patients undergoing …
as higher aspirin doses (500 to … of adverse cardiovascular events among patients undergoing …